These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 10616007

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y.
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [Abstract] [Full Text] [Related]

  • 23. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T.
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [Abstract] [Full Text] [Related]

  • 24. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
    Cabral AR, Cabiedes J, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome.
    Marai I, Gilburd B, Blank M, Shoenfeld Y.
    Hum Antibodies; 2003 Oct; 12(3):57-62. PubMed ID: 14646033
    [Abstract] [Full Text] [Related]

  • 27. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antiphospholipid antibodies in arterial thrombosis.
    Koike T.
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [Abstract] [Full Text] [Related]

  • 30. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
    Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y.
    Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
    [Abstract] [Full Text] [Related]

  • 32. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B.
    Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
    [Abstract] [Full Text] [Related]

  • 33. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F.
    J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
    [Abstract] [Full Text] [Related]

  • 34. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA.
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [Abstract] [Full Text] [Related]

  • 35. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
    Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H.
    Scand J Rheumatol; 2004 Jan; 33(4):246-52. PubMed ID: 15370721
    [Abstract] [Full Text] [Related]

  • 36. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA, van Oort E, Tempelman MJ, Derksen RH, de Groot PG.
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [Abstract] [Full Text] [Related]

  • 37. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 38. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
    Sanmarco M, Roll P, Gayet S, Oksman F, Johanet C, Escande A, Cohen JH, Chevailler A, Goetz J, Humbel RL, Sibilia J.
    J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 40. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct 29; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.